Pharmaceutical preparation and use thereof

US11337972B2 · kind B2 · utility

Assignees

• WUHAN LL SCIENCE AND TECHNOLOGY DEVELOPMENT CO., LTD. · CN
• WUHAN QR PHARMACEUTICALS CO., LTD. · CN
• WUHAN ZY PHARMACEUTICALS CO., LTD. · CN

Inventors

• Xiaojing Hu · 红钢城街道, CN
• Lina QIAN · Hubei, CN
• Zhichao Zhang · Hubei, CN
• Yuanping Wang · Tongren, CN
• Yongkai CHEN · Hubei, CN
• Wei Feng · 梅厂镇, CN
• Wenwen Qi · Hubei, CN
• Chaodong WANG · Hubei, CN

Key dates

• Filing date: Mar 8, 2019
• Grant date: May 24, 2022
• Expiry date: Mar 8, 2039

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61K47/38
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

A pharmaceutical preparation includes a first active component, a second active component and pharmaceutically acceptable excipients. The first active component is at least one selected from the group consisting of a neutral endopeptidase inhibitor and a precursor, an active metabolite, a stereoisomer, a pharmaceutically acceptable salt, a prodrug and a solvate thereof. The second active component is at least one selected from the group consisting of a compound represented by the following formula (I) or a precursor, an active metabolite, a stereoisomer, a pharmaceutically acceptable salt, a prodrug and a solvate thereof. The pharmaceutically acceptable excipients include one or more disintegrants and/or one or more fillers.